Details of the Drug Reposition

General Information of This Drug (ID: DMN37M6)

Drug Name
LY3437943   DMN37M6
Synonyms retatrutide
Drug Type
Peptide

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type 2 diabetes DISJ9M77 5A11 Phase 2 [1]
Obesity DIS47Y1K 5B81 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04867785) A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes. U.S.National Institutes of Health.
2 ClinicalTrials.gov (NCT04881760) A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities. U.S.National Institutes of Health.